SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects

https://doi.org/10.1016/j.dsx.2020.04.033Get rights and content

Highlights

  • Obesity is associated with low-grade inflammation and insulin resistance.

  • SARS-CoV-2 infection triggers an inflammatory cascade and may cause hyperglycemia.

  • Obesity increases vulnerability to SARS-CoV-2, possibly because both diseases share common inflammatory/metabolic pathways.

Abstract

Backround and aims

According to the World Obesity Federation, “obesity-related conditions seem to worsen the effect of Covid-19 (SARS-CoV-2)”; additionally the Centres for Disease Control and Prevention reported that “people with heart disease and diabetes are at higher risk of SARS-CoV-2 complications and that severe obesity poses a higher risk for severe illness”. Recent reports have shown elevated levels of cytokines due to increased inflammation in patients with SARS-CoV-2 disease. On the other hand, obesity represents a state of low-grade inflammation, with various inflammatory products directly excreted by adipose tissue. In this concise report we aimed to assess common elements of obesity and SARS-CoV-2 infection.

Methods

Pubmed search on obesity and SARS-CoV-2 infection.

Results

We present “mechanistic” obesity-related problems that aggravate SARS-CoV-2 infection as well as tentative inflammatory/metabolic links between these diseases.

Conclusion

Obesity and SARS-CoV-2 share common elements of the inflammatory process (and possibly also metabolic disturbances), exacerbating SARS-CoV-2 infection in the obese.

Keywords

Human
Coronavirus
Obesity
Glucose
Inflammation
Infection

Cited by (0)

View Abstract